1. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.

    South Dakota journal of medicine 60(11):437, 439 (2007) PMID 18196687

    Anxiety disorders often coexist with substance use and complicate treatment by causing non-adherence and relapse. Optimal treatment generally involves the treatment of anxiety along with the treatment of substance abuse. Substance-abuse treatment generally involves individual and group therapy, ...
  2. Impact of problem alcohol use on patient behavior and caregiver burden in a geriatric assessment clinic.

    Journal of Geriatric Psychiatry and Neurology 20(2):120 (2007) PMID 17548783

    There has been a growing interest in understanding issues surrounding alcohol use in late life. Information about the relationship of alcohol use to behavioral problems in older persons living in the community is particularly limited. This study used information obtained from an outpatient geria...
  3. Differences in the self-reported reasons for adolescent drug use reported at admission vs. reported at discharge.

    South Dakota journal of medicine 60(6):225, 227 (2007) PMID 17649861

    There are several possible reasons for adolescents' alcohol and drug abuse. While genetic, social and cultural factors all play a part in influencing their behavior of using alcohol and drugs, their self-reported reasons may also offer insight into why they use. Adolescents reported using alcoho...
  4. Possible carbamazepine toxicity with terbinafine.

    The Canadian journal of clinical pharmacology =... 13(2):e228 (2006) PMID 16820654

    To report a case of carbamazepine and terbinafine interaction resulting in an elevated level of carbamazepine and associated symptoms of toxicity. A 50-year-old Caucasian man developed an elevated carbamazapine level after starting terbinafine, which caused symptoms of toxicity with gait ataxia,...
  5. Use of alcoholic beverages in VA medical centers.

    Substance Abuse Treatment, Prevention, and Policy 1:30 (2006) PMID 17052353 PMCID PMC1624810

    Benzodiazepines are the first-line choice for the treatment of alcohol withdrawal syndrome. However, several hospitals continue to provide alcoholic beverages through their formulary for the treatment of alcohol withdrawal. While there are data on the prevalence of this practice in academic medi...
  6. Aripiprazole reduces alcohol use.

    Canadian Journal of Psychiatry 50(4):244 (2005) PMID 15898470

  7. Internet gaming addiction.

    Canadian Journal of Psychiatry 49(12):869 (2004) PMID 15679222

  8. Internet gaming addiction.

    Canadian Journal of Psychiatry 49(12):869 (2004) PMID 15679222

  9. Patient and physician attitudes to using medications with religiously forbidden ingredients.

    Annals of Pharmacotherapy 38(11):1830 (2004) PMID 15479773

    Over 1000 medications contain pork- and/or beef-derived gelatin and stearic acid as inert ingredients. Use of these medications in patients with religious beliefs against consumption of these ingredients might constitute an ethical conflict. To assess patients' and physicians' attitudes about us...
  10. Potential benefits of quetiapine in the treatment of substance dependence disorders.

    Journal of Psychiatry and Neuroscience 29(6):452 (2004) PMID 15644986 PMCID PMC524962

    Some antipsychotic medications prescribed for the treatment of psychoses, mood disorders or post-traumatic stress disorder in patients with coexisting substance dependence disorders (SDD) have reduced substance dependence. We studied the potential benefits of quetiapine in the treatment of SDD. ...
  11. Inert medication ingredients causing nonadherence due to religious beliefs.

    Annals of Pharmacotherapy 38(4):621 (2004) PMID 14766995

    To report 4 cases of medication nonadherence due to presence of inert ingredients forbidden by the patients' religion. We describe 4 cases in which religious concerns about prescribed medications' inert components led to discontinuation of these medications. These inert components are gelatin an...
  12. Aripiprazole possibly worsens psychosis.

    International Clinical Psychopharmacology 19(1):45 (2004) PMID 15101571

    Aripirazole is a novel antipsychotic that functions as a partial agonist at the dopamine D2 receptor and, thus, might theoretically worsen psychosis. We report a series of four clinical cases of exacerbation of psychosis related to initiation of aripiprazole therapy. Cases 1 and 2 demonstrated t...
  13. Addiction training scale: pilot study of a self-report evaluation tool for psychiatry residents.

    Academic Psychiatry 28(3):204 (2004) PMID 15507555

    Alcohol and drug dependence disorders have become common public health hazards. Psychiatrists encounter these problems in a major portion of their patients. However, recent data suggest that their training does not provide them the confidence to treat these disorders. Current methods of evaluati...
  14. Countering countertransference, II: beyond evaluation to cross-examination.

    Journal of the American Academy of Psychiatry a... 32(2):148 (2004) PMID 15281415

    Countertransference is a clinical term introduced by Freud in 1909. For years, despite mounting criticism, forensic psychiatrists borrowed this clinical concept to explain their emotional experiences and responses to examinees' emotions and behavior. The authors describe the impact of examinee a...
  15. Diagnosis and treatment of alcohol dependence in older alcoholics.

    Clinics in Geriatric Medicine 19(4):743 (2003) PMID 15024810

    Treatment of alcohol dependence among older alcoholic patients should be multidimensional to address as many potential relapse factors as possible. As the literature suggests, alcohol-related disorders often are under diagnosed and under treated. More efforts are needed to identify and improve d...
  16. Somnambulism due to probable interaction of valproic acid and zolpidem.

    Annals of Pharmacotherapy 37(10):1429 (2003) PMID 14519043

    To report a case of somnambulism due to a probable interaction between valproic acid and zolpidem in a patient with no prior personal or family history of somnambulism. A 47-year-old white man with a history of bipolar disorder was being maintained on citalopram 40 mg once daily and zolpidem 5 m...
  17. Olanzapine for cocaine cravings and relapse prevention.

    Journal of Clinical Psychiatry 64(8):969 (2003) PMID 12927016

  18. Potential use of olanzapine in treatment of substance dependence disorders.

    Journal of Clinical Psychopharmacology 23(4):413 (2003) PMID 12920420

  19. Use of adjunctive novel antipsychotics with depot haloperidol.

    Psychiatric Services 54(7):1040 (2003) PMID 12851447

  20. A case of venlafaxine abuse.

    New England Journal of Medicine 348(8):764 (2003) PMID 12594330